Gefitero Tablet | 10 Tablets in 1 Strip

Introduction of Gefitero Tablet

Gefitero Tablet is a medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body in patients with abnormal EGFR genes who have not had previous cancer treatment. However, this particular drug, Gefitero 250 mg Tablet, is not suitable for use in children or adolescents because of unknown safety and effectiveness in these age groups.

Gefitero Tablet can cause various side effects, including diarrhea, rash and nausea. It may also cause potentially serious side effects such as liver damage and lung inflammation. If you experience any side effects while taking Gefitero 250 mg, it is important to discuss them with your doctor. It is important to note that if you are allergic to Gefitero 250 mg Tablet or any of its ingredients, you should not use Gefitero 250 Tablet. If you are pregnant, planning to become pregnant or breastfeeding, it is advisable to consult your doctor before using this medicine.

Before starting Gefitero Tablet, it is important to have a conversation with your doctor about the potential risks and benefits associated with this medication. You should also discuss any other questions or concerns you may have. It is also important to tell your doctor about any medical conditions you have and any other medicines, vitamins, supplements or herbal products you are currently taking.

Uses of Gefitero Tablet

​Non-small cell lung cancer: Gefitero Tablet is prescribed for the treatment of non-small cell lung cancer, a form of lung cancer that impacts a significant number of cells within the lung.

Benefits of Gefitero Tablet

Gefitero 250 Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Gefitero 250 mg may help to slow the progression of cancer.

Gefitero 250 mg Tablet may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.

Gefitero Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects of Gefitero Tablet

As with all medicines, Gefitero Tablet may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.

Most Common Side Effects of Gefitero Tablet

• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
  

Common Side Effects of Gefitero Tablet

• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
  

How to Use Gefitero Tablet?

It is recommended to consume Gefitero Tablet with or without food. Ensure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.

How Gefitero Tablet Works?

Gefitero 250 mg Tablet works by inhibiting the activity of the epidermal growth factor receptor (EGFR) protein, which is found on the surface of cells and is involved in the growth and proliferation of cancer cells. When EGFR is activated, it sends signals to the inside of the cell to grow and divide. Gefitero 250 mg binds to the EGFR and prevents it from activating, thereby inhibiting the growth and proliferation of cancer cells.

Safety Advices Gefitero Tablet

Alcohol

Unsafe

Kidney

Use with Caution

Liver

Use with Caution

Driving

Unsafe

Pregnancy

Unsafe

Breastfeeding

Unsafe

References

1. Gefitinib Tablets, Natco Pharma (Canada) Inc. Mississauga, Product Leaflet 

2. Iressa 250 Mg Film-coated Tablets, AstraZeneca Ab, Product Monograph 

3. Summary Of Risk Management Plan For Gefitinib 250 Mg Film-coated Tablets, Qilu Pharma Spain S.l. Available Form 

4. Iressa (gefitinib Tablets, AstraZeneca Pharmaceuticals Lp, Uk, Product Monograph 

5. Iressa 250 Mg Film Coated Tablets, AstraZeneca Limited, Product Leaflet 

6. Gefitinib 250 Mg Film-coated Tablet, Available Form